Showing results (11-20 of 37) with videos related to
Sort By:
Pageof 4
Annals of Cardiothoracic Surgery|February 24, 2016
Multi-institutional European experience of robotic thymectomy for thymomaGiuseppe Marulli, Jos Maessen, Franca Melfi, et al.Thorax|September 24, 2010
Health-related quality of life in patients surviving non-small cell lung cancerJanneke P C Grutters, Manuela A Joore, Erwin M Wiegman, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2006
Time between the first day of chemotherapy and the last day of chest radiation is the most important predictor of survival in limited-disease small-cell lung cancerDirk De Ruysscher, Madelon Pijls-Johannesma, Søren M Bentzen, et al.International Journal of Radiation Oncology, Biology, Physics|November 27, 2007
HI-CHART: a phase I/II study on the feasibility of high-dose continuous hyperfractionated accelerated radiotherapy in patients with inoperable non-small-cell lung cancerDirk De Ruysscher, Rinus Wanders, Erik van Haren, et al.International Journal of Radiation Oncology, Biology, Physics|February 15, 2005
Increased therapeutic ratio by 18FDG-PET CT planning in patients with clinical CT stage N2-N3M0 non-small-cell lung cancer: a modeling studyAntoinet van Der Wel, Sebastiaan Nijsten, Monique Hochstenbag, et al.European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|September 20, 2014
Robotic thymectomy in patients with myasthenia gravis: neurological and surgical outcomesMarlies Keijzers, Marc de Baets, Monique Hochstenbag, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 12, 2014
A phase I study of concurrent individualized, isotoxic accelerated radiotherapy and cisplatin-vinorelbine-cetuximab in patients with stage III non-small-cell lung cancerAnne-Marie C Dingemans, Gerben Bootsma, Angela van Baardwijk, et al.International Journal of Radiation Oncology, Biology, Physics|September 25, 2007
Tumor volume combined with number of positive lymph node stations is a more important prognostic factor than TNM stage for survival of non-small-cell lung cancer patients treated with (chemo)radiotherapyCary Dehing-Oberije, Dirk De Ruysscher, Hiska van der Weide, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 7, 2009
Increased (18)F-deoxyglucose uptake in the lung during the first weeks of radiotherapy is correlated with subsequent Radiation-Induced Lung Toxicity (RILT): a prospective pilot studyDirk De Ruysscher, Ans Houben, Hugo J W L Aerts, et al.Diagnostic Pathology|November 6, 2015
Expression of pRb and p16INK4 in human thymic epithelial tumors in relation to the presence of human polyomavirus 7Marlies Keijzers, Dorit Rensspiess, Sreedhar Pujari, et al.Pageof 4